Table 1.

Clinical practice guidelines for management of pregnancy in persons with primary immune thrombocytopenia.

Recommended Management	Strength of Recommendation	Society
During Pregnancy
Platelet count <30 × 109/L or symptomatic bleeding causes the pregnant patient to receive either corticosteroids or intravenous immune globulin (IVIg)	Strong recommendation	American Society of Hematology [8]
Treatment should be initiated if platelet count <30 × 109/L, or if there is symptomatic bleeding, or to increase platelet counts to a level considered safe for procedures	Conditional suggestion	American College of Obstetricians and Gynecologists [10]
During or for Delivery
Mode of delivery (vaginal vs. cesarean section) should be based on obstetric concerns (platelet count threshold not indicated)	Conditional suggestion	American Society of Hematology [8]
Treatment should be initiated for platelet counts <50 × 109/L for a cesarean delivery	Conditional suggestion	American College of Obstetricians and Gynecologists [10]
Treatment should be initiated for platelet counts <70 × 109/L for an epidural placement	Conditional suggestion	American College of Obstetricians and Gynecologists [10]